Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Therapeutic Implications
100%
Melanoma
100%
Antigen Presentation
100%
Harmine
100%
β-carboline
100%
Anti-programmed Cell Death Protein 1 (anti-PD-1)
100%
MHC-I
100%
TAP1
33%
Melanoma Patients
33%
High-level Expression
22%
Melanoma Cells
22%
Tapasin
22%
Tumor
11%
Overexpression
11%
Cancer Patients
11%
CD8+ T Cells
11%
Expression Level
11%
MRNA Expression
11%
In Cancer
11%
Survival Benefit
11%
Hereafter
11%
Biological Properties
11%
B16F10 Melanoma
11%
Anti-PD-1 Therapy
11%
Pharmacological Properties
11%
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A
11%
NK Cell Markers
11%
Melanoma B16
11%
Tumor Immune Landscape
11%
Proinflammatory Chemokines
11%
CD8 Cells
11%
Biochemistry, Genetics and Molecular Biology
Major Histocompatibility Complex
100%
Antigen Presentation
100%
TAP1
22%
CD8
22%
Tapasin
22%
PD-L1
11%
Tyrosine
11%
Transporter Associated with Antigen Processing
11%
T Cell
11%
Kinase
11%
Phosphotransferase
11%
Chemokine
11%
Natural Killer Cell
11%
Cell Marker
11%
Messenger RNA
11%
Expression Level
11%
Immunology and Microbiology
Antigen Presentation
100%
Major Histocompatibility Complex
100%
Melanoma Cell
22%
Cytotoxic T-Cell
11%
Immune Landscape
11%
Natural Killer Cell
11%
Antigen
11%
Programmed Death-Ligand 1
11%
Cell Marker
11%
CD8
11%
Chemokine
11%
Tyrosine
11%
Kinase
11%
Phosphotransferase
11%